Higher circulating expression levels of miR-221 associated with poor overall survival in renal cell carcinoma patients
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Higher circulating expression levels of miR-221 associated with poor overall survival in renal cell carcinoma patients
Authors
Keywords
Renal cell carcinoma, Plasma circulating miRs, miR-221/222, Noninvasive biomarkers
Journal
TUMOR BIOLOGY
Volume 35, Issue 5, Pages 4057-4066
Publisher
Springer Nature
Online
2013-12-31
DOI
10.1007/s13277-013-1531-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- RETRACTED: Construction of circular miRNA sponges targeting miR-21 or miR-221 and demonstration of their excellent anticancer effects on malignant melanoma cells
- (2013) Yuchen Liu et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Non-Coding RNAs and Cancer
- (2013) Federica Calore et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Renal cell carcinoma development and miRNAs: a possible link to the EGFR pathway
- (2013) Francisca Dias et al. PHARMACOGENOMICS
- Comprehensive microRNA Profiling of Prostate Cancer
- (2013) Beatriz A. Walter et al. Journal of Cancer
- Analysis of serum microRNAs (miR-26a-2*, miR-191, miR-337-3p and miR-378) as potential biomarkers in renal cell carcinoma
- (2012) Stefan Hauser et al. Cancer Epidemiology
- Circulating and Urinary microRNAs in Kidney Disease
- (2012) J. M. Lorenzen et al. Clinical Journal of the American Society of Nephrology
- Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma
- (2012) An Zhao et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Multifunction Protein Staphylococcal Nuclease Domain Containing 1 (SND1) Promotes Tumor Angiogenesis in Human Hepatocellular Carcinoma through Novel Pathway That Involves Nuclear Factor κB and miR-221
- (2012) Prasanna Kumar Santhekadur et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- High level of miR-221/222 confers increased cell invasion and poor prognosis in glioma
- (2012) Chunzhi Zhang et al. Journal of Translational Medicine
- Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma
- (2012) Martina Redova et al. Journal of Translational Medicine
- A Genetic Variant in pre-miR-27a Is Associated with a Reduced Renal Cell Cancer Risk in a Chinese Population
- (2012) Danni Shi et al. PLoS One
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The functional significance of miR-1 and miR-133a in renal cell carcinoma
- (2011) Kazumori Kawakami et al. EUROPEAN JOURNAL OF CANCER
- Accurate Molecular Classification of Kidney Cancer Subtypes Using MicroRNA Signature
- (2011) Youssef M. Youssef et al. EUROPEAN UROLOGY
- MicroRNA in Prostate, Bladder, and Kidney Cancer: A Systematic Review
- (2011) James W.F. Catto et al. EUROPEAN UROLOGY
- miR-221 and miR-222 expression increased the growth and tumorigenesis of oral carcinoma cells
- (2011) Chun-Ju Yang et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- MicroRNAs in Renal Cell Carcinoma: Diagnostic Implications of Serum miR-1233 Levels
- (2011) Lena M. Wulfken et al. PLoS One
- The von Hippel-Lindau Tumor Suppressor Protein Promotes c-Cbl-Independent Poly-Ubiquitylation and Degradation of the Activated EGFR
- (2011) Liang Zhou et al. PLoS One
- MicroRNAs miR-221 and miR-222: a new level of regulation in aggressive breast cancer
- (2011) Maitri Y Shah et al. Genome Medicine
- MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN
- (2010) Zhang Chun-zhi et al. BMC CANCER
- Prognostic factors for survival in metastatic renal cell carcinoma
- (2010) Ronald M. Bukowski CANCER
- Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression
- (2010) Xing-xiang Pu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways
- (2010) X Rao et al. ONCOGENE
- MicroRNAs and pharmacogenomics
- (2010) Noam Shomron PHARMACOGENOMICS
- Renal cell carcinoma bone metastases: clinical advances
- (2010) Chakshu Sahi et al. Therapeutic Advances in Medical Oncology
- MicroRNAs are novel biomarkers of colorectal cancer
- (2009) M. I. Aslam et al. BRITISH JOURNAL OF SURGERY
- RNA and Disease
- (2009) Thomas A. Cooper et al. CELL
- MicroRNA-221 Targets Bmf in Hepatocellular Carcinoma and Correlates with Tumor Multifocality
- (2009) L. Gramantieri et al. CLINICAL CANCER RESEARCH
- MicroRNAs and cancer—new paradigms in molecular oncology
- (2009) Massimo Negrini et al. CURRENT OPINION IN CELL BIOLOGY
- MicroRNAs and prostate cancer
- (2009) Valeria Coppola et al. ENDOCRINE-RELATED CANCER
- Targeting Renal Cell Carcinoma
- (2009) Robert J. Motzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic factors for renal cell carcinoma
- (2008) D. Furniss et al. CANCER TREATMENT REVIEWS
- No improvement in renal cell carcinoma survival: A population-based study in the Netherlands
- (2008) K.K.H. Aben et al. EUROPEAN JOURNAL OF CANCER
- Genetic basis for kidney cancer: opportunity for disease-specific approaches to therapy
- (2008) Elizabeth Cartwright Pfaffenroth et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1
- (2008) Tyler E. Miller et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Activated Akt as an indicator of prognosis in gastric cancer
- (2008) Caterina Cinti et al. VIRCHOWS ARCHIV
- PTENpolymorphisms and the risk of esophageal carcinoma and gastric cardiac carcinoma in a high incidence region of China
- (2007) H. Ge et al. DISEASES OF THE ESOPHAGUS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started